<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20150424021917N11</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-12-22</date_registration>
      <primary_sponsor>Vice Chancellor for Research and Technology University of Medical Sciences</primary_sponsor>
      <public_title>Effect of cup, syringe and finger feeding on timing of complete oral feeding and weight gain in preterm infants: a randomized controlled clinical trial</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of the effect of cup, syringe and finger feeding on timing of complete oral feeding and weight gain in preterm infants: a randomized controlled clinical trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2020-12-21</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>99</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/52626</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Diagnostic, Randomization description: Participants will be randomly assigned to  three groups of finger feeding, cup feeding, and syringe feeding blocks with blockes size 6 and 9  ratio of 1: 1. The allocation sequence will be determined using Random Allocation Software (RAS). To  allocation cocealment, the type of intervention will be written on paper and placed in sealed opaque envelopes that are numbered sequentially. The envelopes will be opened by the person not involved in the sampling.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Premature neonate.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group 1: 33 premature infants will be breastfed or complementary milk with a 50 ml disposable plastic cup.The baby is kept in a sitting or semi-sitting position with head-body coordination.The edge of the cup is placed on the lower lip of the baby and the baby sucks the milk from the cup with forward movements of the tongue. Intervention 2: Intervention group 2: 33 premature infants will be fed with breast milk or complementary milk through a gavage tube attached to the mother's finger.In this method, breast milk or auxiliary milk is poured into a syringe and a gastric tube is attached to it. After washing the hands and wearing disposable gloves, the researcher or mother will glue the stomach tube to her little finger. By placing a finger in the baby's mouth and sucking, the milk will be transferred to the baby's mouth through the stomach tube. Intervention 3: Intervention group 3: 33 premature infants will be fed breast milk or complementary milk through a syringe.In this feeding method, the piston is squeezed while the premature baby is sucking and the milk is directed to the inside of the cheek.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Only part of the data such as information about the main outcome or the like can be shared. The results of the clinical study will be published as an article.

When:
Access period starts 6 months after the results are published

To whom:
All researchers

Conditions:
Scientific use with reference to the article

Where to obtain:
sevil hakimi - hakimis@tbzmed.ac.ir

How to obtain:
The applicant notifies the applicant by email, after receiving the email the results are sent.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Parinaz Alinazhad Shebilouy Sofla</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>South Shariati St., School of Nursing and Midwifery, Tabriz University Of Medical Sciences</address>
        <city>Tabriz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5138947977</zip>
        <telephone>+98 912 603 5672</telephone>
        <email>Pr.alinezhad@gmail.com</email>
        <affiliation>Tabriz University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Sevil Hakimi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>South Shariati St., School of Nursing and Midwifery, Tabriz University of Medical Sciences</address>
        <city>Tabriz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5138947977</zip>
        <telephone>0414796770</telephone>
        <email>hakimis@tbzmed.ac.ir</email>
        <affiliation>Tabriz University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>The age of the infant at the time of sampling is 30-34 weeks with stable clinical condition
Ability to swallow of newborn for two days
Apgar minute 5 higher than 7</inclusion_criteria>
      <agemin>210 days</agemin>
      <agemax>238 days</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Intra Ventricular Hemorrhage grade 3 or 4
Sepsis
Newborn under CPAP or ventilator
Congenital malformation
Down Syndrome
Neuromuscular diseases</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>P07.33</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>premature neonate, gestational age 30 completed weeks</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Other</i_code>
      <i_code>Other</i_code>
      <i_code>Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group 1: 33 premature infants will be breastfed or complementary milk with a 50 ml disposable plastic cup.The baby is kept in a sitting or semi-sitting position with head-body coordination.The edge of the cup is placed on the lower lip of the baby and the baby sucks the milk from the cup with forward movements of the tongue.</i_keyword>
      <i_keyword>Intervention group 2: 33 premature infants will be fed with breast milk or complementary milk through a gavage tube attached to the mother's finger.In this method, breast milk or auxiliary milk is poured into a syringe and a gastric tube is attached to it. After washing the hands and wearing disposable gloves, the researcher or mother will glue the stomach tube to her little finger. By placing a finger in the baby's mouth and sucking, the milk will be transferred to the baby's mouth through the stomach tube.</i_keyword>
      <i_keyword>Intervention group 3: 33 premature infants will be fed breast milk or complementary milk through a syringe.In this feeding method, the piston is squeezed while the premature baby is sucking and the milk is directed to the inside of the cheek.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Time to reach complete oral nutrition. Timepoint: Before the intervention and then after the intervention. Method of measurement: Using a researcher-made questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>The rate of weight change. Timepoint: The baby's weight will be measured at the beginning of the study and then daily at a specific time in the morning shift before feeding and then after feeding the baby daily until full oral feeding. Method of measurement: Weight in grams with a digital scale.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Vice Chancellor for Research and Technology University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2020-11-25</approval_date>
        <contact_name>Ethics committee of Tabriz University of Medical Sciences</contact_name>
        <contact_address>Third Floor, Central Building of Number 2, Golgasht Street Tabriz East Azarbaijan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
